Can the Pancreas Recover?

The human body has a remarkable ability to respond when harmful metabolic pressures are reduced.

For people with type 2 diabetes, one of the most interesting discoveries of the past decade is that the pancreas may sometimes recover a surprising amount of its lost function when blood sugar control improves, excess fat stored in the liver and pancreas is reduced, and substantial weight loss is maintained.

That does not mean the adult pancreas simply “grows back,” nor does it mean type 2 diabetes has been permanently cured.

But research does show that, in some people, insulin-producing beta cells that had been functioning poorly can begin working much better again.

That distinction is important.

Not in the way the word regeneration is usually understood.

The remission studies discussed here do not establish that the adult human pancreas creates large numbers of new insulin-producing beta cells.

What appears to happen in successful type 2 diabetes remission is more accurately described as functional recovery.

Beta cells that were struggling to respond properly to glucose may regain substantial insulin-producing capacity when the metabolic environment improves.

In other words:

The pancreas may not be replacing itself with an entirely new pancreas—but parts of it may begin functioning much more normally again.

These remission studies demonstrate improved function, not proof that large numbers of new beta cells were created.

Type 2 diabetes is not simply a condition caused by eating sugar.

It involves a combination of factors that can include:

• insulin resistance
• genetics
• body-fat distribution
• physical activity
• age
• liver metabolism
• pancreatic beta-cell function

In many people with type 2 diabetes, excess fat accumulates not only under the skin but also inside organs such as the liver and pancreas.

Research supported by Diabetes UK has shown that reducing excess fat stored in these organs can improve the body's ability to regulate blood glucose and, in some people, lead to type 2 diabetes remission.

When blood glucose remains elevated for long periods, the insulin-producing beta cells also operate in a difficult metabolic environment.

Reducing that metabolic stress can allow some surviving beta cells to work more effectively.

One of the most important findings from diabetes-remission research is that substantial weight loss can reduce fat stored in the pancreas.

When that happens, insulin secretion can improve.

In a detailed follow-up from the Diabetes Remission Clinical Trial, or DiRECT, researchers studied people who had achieved remission after substantial weight loss.

Among those remaining in remission, the pancreas's maximum insulin-secretion capacity gradually improved.

By approximately 12 months, maximum beta-cell functional capacity had become comparable to that measured in the study's non-diabetic comparison group, and that improvement was maintained at 24 months.

The earliest insulin response did improve substantially but did not completely normalize, illustrating why the word recovery is more appropriate than claiming the pancreas had become completely new.

The changes may not be limited to insulin secretion.

MRI research associated with DiRECT found that people who achieved remission experienced improvements in the size and shape of the pancreas.

In a post-hoc MRI analysis of a subset of DiRECT participants, pancreas volume increased among those in remission over two years, and measures of pancreatic shape improved. These subgroup findings should not be applied to everyone with type 2 diabetes.

Researchers believe these structural changes may reflect improving pancreatic health as fat within the pancreas decreases and normal metabolic signaling improves.

This is fascinating evidence of pancreatic remodeling and recovery, but it should not be interpreted as proof that adults can routinely regenerate an entirely damaged pancreas.

The DiRECT trial provides some of the best-known data.

Participants had relatively recently diagnosed type 2 diabetes and received an intensive weight-management program.

After 1 year

Approximately 46% of participants receiving the weight-management intervention were in remission.

After 2 years

Approximately 36% remained in remission.

Greater weight loss produced much higher remission rates

Among participants who lost at least 15 kilograms—about 33 pounds—86% achieved remission at one year.

That does not mean everyone needs to lose 33 pounds.

The amount needed varies from person to person.

Remission is more likely in people who have had type 2 diabetes for a shorter time and whose pancreas retains more function when treatment begins. These trial results are not a personal weight-loss target; discuss an appropriate approach with your healthcare team.

Sometimes—but maintaining it can be difficult.

At five years, DiRECT follow-up data showed that:

• In the selected DiRECT extension group, 11 of 85 participants (13%) who continued receiving structured support were in remission at five years. This is not a five-year remission rate for all original intervention participants.
• People who maintained remission tended to maintain more of their weight loss.

This is why researchers use the word remission, not cure.

Blood sugar can return to the diabetes range, particularly if weight is regained and fat again accumulates in the liver and pancreas.

An international expert group convened by organizations including the American Diabetes Association proposed a clear definition.

Type 2 diabetes remission generally means:

HbA1c below 6.5% for at least three months without the usual glucose-lowering medication.

Remission does not mean a person should stop monitoring their health.

Regular diabetes follow-up, including appropriate eye, kidney, cardiovascular, and other screening, remains important because previous diabetes still carries health implications.

In a practical sense, a healthier eating pattern can reduce metabolic stress—but “pancreatic load” is not a precise medical measurement.

A better way to describe it is:

Healthy eating can help reduce metabolic demand.

Eating patterns that help someone achieve and maintain an appropriate weight can improve insulin sensitivity and reduce the amount of insulin the body must produce to control the same amount of glucose.

Lower blood glucose can reduce glucotoxic stress.

Persistently high glucose can interfere with normal beta-cell function. Improving glucose control can allow surviving beta cells to work in a healthier environment.

Weight loss can reduce fat stored in the liver and pancreas.

This appears to be particularly important in the remission research.

Better food quality can support long-term weight and cardiovascular management.

Vegetables, legumes, whole grains, fish, lean proteins, nuts, seeds, and minimally processed foods can make it easier to build a sustainable eating pattern while controlling calories, saturated fat, sodium, and added sugars.

The benefit comes from the overall metabolic improvement, not from a single “pancreas-healing” food.

This needs an important clarification.

Diabetes medications should not be thought of simply as a harmful “drug load” on the pancreas.

Many diabetes medications lower glucose and may actually reduce the metabolic stress associated with poorly controlled diabetes.

Some medications also protect the heart, kidneys, or both.

When people enter a medically supervised remission program, medications sometimes need to be reduced or stopped because blood glucose falls rapidly—but those decisions should be made with a healthcare professional.

Do not stop insulin, diabetes medications, blood-pressure drugs, cholesterol medication, or other prescribed treatment simply because you begin eating healthier.

A successful lifestyle change may eventually allow some people to reduce medication, but medication reduction should be the result of improving health, not the starting assumption.

The remission research discussed here primarily concerns type 2 diabetes.

Type 1 diabetes involves autoimmune destruction of insulin-producing beta cells.

Current evidence does not show that dietary changes can regenerate enough beta cells in adults with type 1 diabetes to eliminate the need for insulin.

People with type 1 diabetes should never stop insulin in an attempt to allow the pancreas to “recover.”

Pancreatitis, pancreatic surgery, pancreatic cancer, cystic fibrosis-related diabetes, and other pancreatic diseases are different conditions from typical type 2 diabetes.

The remission statistics from DiRECT should not be applied to those conditions.

Anyone with known pancreatic disease should follow guidance from their medical team.

Perhaps the most encouraging part of this research is not the idea that the pancreas literally grows back.

It is that poor pancreatic function in type 2 diabetes is not always completely irreversible.

For some people—particularly earlier in the disease process—substantial and maintained weight loss can:

• reduce liver fat
• reduce pancreatic fat
• improve insulin sensitivity
• improve beta-cell function
• reduce blood glucose
• reduce the need for glucose-lowering medication
• and sometimes place type 2 diabetes into remission

In the reported evaluation of the NHS England Type 2 Diabetes Path to Remission program, 945 of 1,740 starters completed the year-long program. Approximately 32% of completers achieved remission, with average weight loss of about 16 kilograms among completers. This is not the remission rate for everyone referred to or starting the program.

That is an important reminder that these findings are not limited to a single laboratory experiment.

The goal does not need to be an extreme or perfect diet.

The most sustainable approach is usually one that helps a person consistently:

• control portions
• reduce excess calories
• limit added sugars
• emphasize whole and minimally processed foods
• eat plenty of vegetables and high-fiber foods
• choose healthier fats
• control sodium and saturated fat
• maintain an appropriate weight
• remain physically active
• monitor blood glucose when needed

For someone living with type 2 diabetes, meaningful dietary changes can sometimes do much more than simply improve today's glucose reading.

They may help create an internal environment in which the pancreas—and the rest of the body's metabolic system—can work better again.

The science of type 2 diabetes remission has changed how researchers think about the disease.

For some people, especially earlier after diagnosis, the pancreas can regain a remarkable amount of function when substantial weight loss is achieved and maintained.

But remission is not guaranteed.

It is not the same as a cure.

And the evidence does not support telling adults that their pancreas will simply regenerate if they stop medication or remove certain foods.

What the evidence does support is powerful enough:

The body can sometimes recover more function than we once thought possible.

Improving the foods you eat, reducing excess weight when appropriate, staying active, and working with your healthcare team can give your metabolism—and your pancreas—the best environment possible to function well.

Healthy choices cannot promise a cure.

But they can give the body something extremely valuable:

a better opportunity to do what it was designed to do.

Important health information

This article provides general educational information and is not medical advice. Type 2 diabetes remission should be pursued with appropriate medical supervision, particularly for anyone taking insulin, sulfonylureas, blood-pressure medication, or other medicines that may need adjustment as weight or blood glucose changes.

Never stop or change prescribed medication without discussing it with the healthcare professional managing your treatment.